SCHEMBL3756674

SCHEMBL3756674

CN(C)C(=O)c1cccc(-c2cccc(-c3c(N4CCOCC4)sc4c3CC(C)(C)CC4=O)n2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 1/20 0.39
PIK3CA P42336 4/20 0.39
PIK3CD O00329 2/20 0.39
PIK3CB P42338 2/20 0.39
PIK3CG P48736 2/20 0.39
ATR Q13535 1/20 0.38
ATRIP Q8WXE1 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
PIK3R1 P27986 2/20 0.37
ADORA2A P29274 1/20 0.36
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 2/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
ALOX15 P16050 1/20 0.36
CYP2C19 P33261 1/20 0.36
FYN P06241 1/20 0.36
LMNA P02545 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3765101 0.92 PIK3CA (0.38) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL3762316 0.89 LRRK2 (0.41) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL3764518 0.86 BRD4 (0.35) PIK3CAPIK3CDPIK3CBPIK3CGATR
SCHEMBL3760142 0.86 PIK3CA (0.45) PIK3CAPIK3CDPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3764433 0.86 MTOR (0.42) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL3752038 0.85 PIK3CA (0.39) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL3769107 0.82 HTR7 (0.40) PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL3754752 0.82 PRKDC (0.45) PIK3CAPIK3CDPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3760529 0.82 PRKDC (0.47) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3761442 0.81 MTOR (0.38) MTORPIK3CAPIK3CDPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA MTOR 7/4885PIK3CA 3/4885PIK3CD 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.